phenobarbital has been researched along with Congenital Myotonic Dystrophy in 1 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walsh, KV | 1 |
| Harley, HG | 1 |
| Brook, JD | 1 |
| Rundle, SA | 1 |
| Sarfarazi, M | 1 |
| Harper, PS | 1 |
| Shaw, DJ | 1 |
1 other study available for phenobarbital and Congenital Myotonic Dystrophy
| Article | Year |
|---|---|
Linkage relationships of the apolipoprotein C1 gene and a cytochrome P450 gene (CYP2A) to myotonic dystrophy.
Topics: Apolipoprotein C-I; Apolipoproteins C; Chromosome Mapping; Chromosomes, Human, Pair 19; Cytochrome P | 1990 |